Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2022-08-16 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Reply to Clarification Sought
Regulatory Filings
2022-08-16 English
Dear Sir, We are seeking approval of the shareholders through e-postal ballot voting for following business. 1. Appointment of Mr. Prashant Godha an Additional Director as a Director ....
Regulatory Filings
2022-08-09 English
General updates
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 183 characters, which is very short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2022-08-09 English
Sub.: Intimation of Reconstitution of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee and Corporate Social Responsibility ....
Regulatory Filings
2022-08-09 English
General updates
Regulatory Filings
2022-08-09 English
The Board of Directors at its meeting held on today appointed Mr. Babulal Jain (DIN: 00016573) as an Independent Director of the Company with effect from 8th August, 2022 for a Term of ....
Regulatory Filings
2022-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.